Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: BLCO ) 20.51 +0.23 (+1.13%) Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about BLCO < Previous 1 2 3 4 5 6 Next > Bausch + Lomb Announces Third-Quarter 2024 Results October 30, 2024 From Bausch + Lomb Corporation Via Business Wire Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt October 26, 2024 IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. Via Benzinga Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags October 21, 2024 S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. Via Benzinga Topics Bankruptcy Stocks Exposures Financial Legal US Equities This Advance Auto Parts Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday October 15, 2024 Via Benzinga Why Bausch + Lomb Rallied Today September 16, 2024 The highly indebted healthcare stock rose on rumors it may be selling itself. Via The Motley Fool Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. Via Benzinga Topics Economy Exposures Interest Rates Why Bausch + Lomb Stock Soared by Over 7% on Monday October 14, 2024 It was quite a busy and eventful day for the company. Via The Motley Fool NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday October 14, 2024 Via Benzinga Topics Government Exposures Political Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces October 14, 2024 Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. Via Benzinga Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens October 14, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30 October 09, 2024 From Bausch + Lomb Corporation Via Business Wire Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session October 02, 2024 Via Benzinga Bausch + Lomb Launches Opal™ Digital Marketplace in the United States October 01, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value September 25, 2024 The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden. Via MarketBeat Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? September 22, 2024 Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. Via Benzinga Topics Economy Exposures Interest Rates Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday September 18, 2024 Via Benzinga Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues September 16, 2024 Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off. Via Benzinga Topics Supply Chain Exposures Supply Chain Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? September 16, 2024 Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns. Via Investor's Business Daily Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday September 16, 2024 Via Benzinga Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? July 31, 2024 Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting. Via Benzinga Topics Economy Exposures Interest Rates Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility July 31, 2024 Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) Via Benzinga Topics Economy Exposures Interest Rates Bausch + Lomb Announces Second-Quarter 2024 Results July 31, 2024 From Bausch + Lomb Corporation Via Business Wire Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 24, 2024 Via Benzinga Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31 July 11, 2024 From Bausch + Lomb Corporation Via Business Wire Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief July 08, 2024 From Bausch + Lomb Corporation Via Business Wire Why Is Clearside Biomedical Stock Gaining Today? June 25, 2024 Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... Via Benzinga Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress June 17, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States June 10, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States June 03, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results May 29, 2024 From Bausch + Lomb Corporation Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
